Spyre Therapeutics Inc. Financial Flexibility Index
Spyre Therapeutics Inc. financial flexibility index. Spyre Therapeutics Inc. (SYRE) has a Financial Flexibility Index of -0.97x as of June 2026. Free cash flow of $-69.88 Million (operating CF $-69.88 Million minus capex $0.00) represents -1% of total liabilities ($71.86 Million). See SYRE free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Spyre Therapeutics Inc. (2014–2025)
Financial flexibility index of Spyre Therapeutics Inc. from 2014 to 2025. Historical Financial Flexibility Index trend for Spyre Therapeutics Inc. across 12 annual periods. Explore Spyre Therapeutics Inc. (SYRE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Spyre Therapeutics Inc. Financial Flexibility Index by Year (2014–2025)
Spyre Therapeutics Inc. financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Spyre Therapeutics Inc.. For the full cash flow conversion analysis, see how efficiently does Spyre Therapeutics Inc. generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.71x | $-169.25 Million | $-169.25 Million | $62.55 Million | ▼ -55.9% |
| 2024 | -1.74x | $-157.41 Million | $-157.41 Million | $90.68 Million | ▼ -174.2% |
| 2023 | -0.63x | $-99.91 Million | $-99.91 Million | $157.84 Million | ▲ +83.5% |
| 2022 | -3.84x | $-80.11 Million | $-80.14 Million | $20.84 Million | ▼ -88.0% |
| 2021 | -2.05x | $-53.14 Million | $-53.72 Million | $25.98 Million | ▲ +37.7% |
| 2020 | -3.28x | $-71.50 Million | $-75.78 Million | $21.79 Million | ▼ -18.1% |
| 2019 | -2.78x | $-64.20 Million | $-65.69 Million | $23.10 Million | ▲ +9.8% |
| 2018 | -3.08x | $-31.77 Million | $-32.19 Million | $10.31 Million | ▲ +26.3% |
| 2017 | -4.18x | $-24.00 Million | $-24.61 Million | $5.74 Million | ▲ +8.1% |
| 2016 | -4.55x | $-18.63 Million | $-18.84 Million | $4.10 Million | ▼ -7.6% |
| 2015 | -4.23x | $-10.77 Million | $-10.98 Million | $2.55 Million | ▲ +37.5% |
| 2014 | -6.76x | $-7.15 Million | $-7.33 Million | $1.06 Million | — |